The Europe Biosurgery Market is expected to witness market growth of 6% CAGR during the forecast period (2019-2025).
Biosurgery technology has established a new paradigm in wound and tissue management, surgical care, and regenerative healing. Several products under biosurgery have brought in extensive interest among surgeons and patients. This is projected to gain traction in several medical specialties such as gynecology, orthopedic, neurosurgery cardiovascular, and spine-related therapies. The increased need for novel biomaterials for the intra-operative wound as well as tissue management can also be a key trend in improving the biosurgery market. Life sciences companies launch products for surgical care that are highly focused on discovering new avenues in biosurgery by getting involved in relentless development activities.
The European Bio Surgery market's main driver is the strong focus on scientific growth, which in turn leads to the launch of various new products and other technological advances in the area. Along with the growing number of surgeries due to evolving lifestyles and increasing consumer awareness, it will serve as market growth boosters. The main critical factor on the Bio Surgery market in Europe is the inability to accept some products, like human tissue, which is necessary for regenerative purposes due to ethical concerns in some parts of the region. This, along with the high costs and the strict regulations of the government, serves as market restrictions.
Based on Application, the market is segmented into General Surgeries, Orthopedic Surgeries, Neurological Surgeries, Cardiovascular Surgeries and Other Applications. Based on Product, the market is segmented into Surgical sealants, Soft Tissue Attachments, Adhesion Barriers, Hemostatic Agents, Bone Graft Substitutes and Other Products. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Baxter International, Inc., Johnson and Johnson, Medtronic PLC, Pfizer, Inc., Stryker Corporation, B. Braun Melsungen AG, Sanofi S.A., Becton, Dickinson and Company, Integra LifeSciences Holdings Corporation and CSL Limited.
Scope of the Study
Market Segmentation:
By Application
By Product
By Country
Companies Profiled
Unique Offerings from the Publisher
Biosurgery technology has established a new paradigm in wound and tissue management, surgical care, and regenerative healing. Several products under biosurgery have brought in extensive interest among surgeons and patients. This is projected to gain traction in several medical specialties such as gynecology, orthopedic, neurosurgery cardiovascular, and spine-related therapies. The increased need for novel biomaterials for the intra-operative wound as well as tissue management can also be a key trend in improving the biosurgery market. Life sciences companies launch products for surgical care that are highly focused on discovering new avenues in biosurgery by getting involved in relentless development activities.
The European Bio Surgery market's main driver is the strong focus on scientific growth, which in turn leads to the launch of various new products and other technological advances in the area. Along with the growing number of surgeries due to evolving lifestyles and increasing consumer awareness, it will serve as market growth boosters. The main critical factor on the Bio Surgery market in Europe is the inability to accept some products, like human tissue, which is necessary for regenerative purposes due to ethical concerns in some parts of the region. This, along with the high costs and the strict regulations of the government, serves as market restrictions.
Based on Application, the market is segmented into General Surgeries, Orthopedic Surgeries, Neurological Surgeries, Cardiovascular Surgeries and Other Applications. Based on Product, the market is segmented into Surgical sealants, Soft Tissue Attachments, Adhesion Barriers, Hemostatic Agents, Bone Graft Substitutes and Other Products. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Baxter International, Inc., Johnson and Johnson, Medtronic PLC, Pfizer, Inc., Stryker Corporation, B. Braun Melsungen AG, Sanofi S.A., Becton, Dickinson and Company, Integra LifeSciences Holdings Corporation and CSL Limited.
Scope of the Study
Market Segmentation:
By Application
- General Surgeries
- Orthopedic Surgeries
- Neurological Surgeries
- Cardiovascular Surgeries
- Other Applications
By Product
- Surgical Sealants
- Soft Tissue Attachments
- Adhesion Barriers
- Hemostatic Agents
- Bone Graft Substitutes
- Other Products
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Companies Profiled
- Baxter International, Inc.
- Johnson and Johnson
- Medtronic PLC
- Pfizer, Inc.
- Stryker Corporation
- B. Braun Melsungen AG
- Sanofi S.A.
- Becton, Dickinson and Company
- Integra LifeSciences Holdings Corporation
- CSL Limited
Unique Offerings from the Publisher
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Competition Analysis - Global
Chapter 4. Europe Biosurgery Market by Application
Chapter 5. Europe Biosurgery Market by Product
Chapter 6. Europe Biosurgery Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Baxter International, Inc.
- Johnson and Johnson
- Medtronic PLC
- Pfizer, Inc.
- Stryker Corporation
- B. Braun Melsungen AG
- Sanofi S.A.
- Becton, Dickinson and Company
- Integra LifeSciences Holdings Corporation
- CSL Limited
Methodology
LOADING...
